COVID-19与静脉血栓栓塞风险:多种族住院人群研究
该回顾性研究纳入6319例实验室确诊COVID-19住院成人及按年龄、性别、种族或民族、急性病严重程度和住院月份匹配的6319例无COVID-19住院成人,比较30天内VTE发生率。结果显示COVID-19患者VTE调整风险是无COVID-19对照的3倍以上(aHR 3.48,95%CI 2.03-5.98),并识别出年龄≥55岁、黑人种族、既往VTE等预测因素。
要点
- COVID-19住院成人30天VTE调整风险为匹配无COVID-19对照的3.48倍(95%CI 2.03-5.98)。
- COVID-19患者VTE预测因素包括年龄≥55岁、黑人种族、既往VTE、脓毒症、中重度肝病、BMI≥40 kg/m2、血小板>217 k/μL。
- 研究人群种族多样(53.1%西班牙裔、14.6%亚裔/太平洋岛民、10.3%黑人),提示结果外推需考虑人群构成。
核心结论
- 在多种族住院成人中,COVID-19感染增加VTE风险,且部分患者特征与COVID-19背景下更高的血栓栓塞风险相关。
研究设计与样本
- 回顾性研究,纳入2020年1月至8月来自两个整合医疗系统36家医院的住院成人。
- COVID-19组为实验室确诊的住院成人,对照组为无COVID-19证据的住院成人,按年龄、性别、种族或民族、急性病严重程度和住院月份匹配。
- 共识别6319例COVID-19成人和6319例匹配无COVID-19成人,平均年龄60.0±17.2岁,46%女性。
主要发现
- 30天随访期间发生313例验证VTE(COVID-19组160例,对照组153例)和1172例死亡(COVID-19组817例,对照组355例)。
- COVID-19成人VTE调整风险显著高于匹配对照(aHR 3.48;95%CI 2.03-5.98)。
- COVID-19患者VTE预测因素包括年龄≥55岁、黑人种族、既往VTE、诊断脓毒症、既往中重度肝病、BMI≥40 kg/m2、血小板计数>217 k/μL。
关键数值与推荐
- VTE结局通过诊断代码结合经过验证的自然语言处理算法从电子健康记录中确认。
- 采用Fine和Gray风险回归评估COVID-19与VTE关联,并考虑死亡竞争风险和组间残余差异。
临床怎么用
- 对住院COVID-19成人应警惕VTE风险,尤其具备年龄≥55岁、黑人种族、既往VTE、脓毒症、中重度肝病、BMI≥40 kg/m2或血小板>217 k/μL等特征者。
- 临床评估VTE风险时可参考本研究识别的预测因素,但需结合具体患者情况和本地诊疗规范。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Limited existing data suggest that the novel COVID-19 may increase risk of VTE, but information from large, ethnically diverse populations with appropriate control participants is lacking. RESEARCH QUESTION: Does the rate of VTE among adults hospitalized with COVID-19 differ from matched hospitalized control participants without COVID-19? STUDY DESIGN AND METHODS: We conducted a retrospective study among hospitalized adults with laboratory-confirmed COVID-19 and hospitalized adults without evidence of COVID-19 matched for age, sex, race or ethnicity, acute illness severity, and month of hospitalization between January 2020 and August 2020 from two integrated health care delivery systems with 36 hospitals. Outcomes included VTE (DVT or pulmonary embolism ascertained using diagnosis codes combined with validated natural language processing algorithms applied to electronic health records) and death resulting from any cause at 30 days. Fine and Gray hazards regression was performed to evaluate the association of COVID-19 with VTE after accounting for competing risk of death and residual differences between groups, as well as to identify predictors of VTE in patients with COVID-19. RESULTS: We identified 6,319 adults with COVID-19 and 6,319 matched adults without COVID-19, with mean ± SD age of 60.0 ± 17.2 years, 46% women, 53.1% Hispanic, 14.6% Asian/Pacific Islander, and 10.3% Black. During 30-day follow-up, 313 validated cases of VTE (160 COVID-19, 153 control participants) and 1,172 deaths (817 in patients with COVID-19, 355 in control participants) occurred. Adults with COVID-19 showed a more than threefold adjusted risk of VTE (adjusted hazard ratio, 3.48; 95% CI, 2.03-5.98) compared with matched control participants. Predictors of VTE in patients with COVID-19 included age ≥ 55 years, Black race, prior VTE, diagnosed sepsis, prior moderate or severe liver disease, BMI ≥ 40 kg/m2, and platelet count > 217 k/μL. INTERPRETATION: Among ethnically diverse hospitalized adults, COVID-19 infection increased the risk of VTE, and selected patient characteristics were associated with higher thromboembolic risk in the setting of COVID-19.
引用
- Go AS, Reynolds K, Tabada GH, et al. COVID-19 and Risk of VTE in Ethnically Diverse Populations. Chest. 2021. PMID: 34293316. doi:10.1016/j.chest.2021.07.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。